2018 SITC Fellowship Recipients

SITC is proud to announce the recipients of the 2018 Cancer Immunotherapy Fellowships Awards. Established through the Forward Fund, the SITC Fellowship Award program supports the development of young investigators in the field to cultivate the next generation of cancer immunotherapy experts.

SITC would like to thank AstraZeneca Pharmaceuticals LP, Bristol- Myers Squibb, Merck & Co. Inc. and the National Cancer Institute for helping to make these awards possible.

SITC-AstraZeneca Postdoctoral Cancer Immunotherapy in Combination Therapies Clinical Fellowship Award

Bryan D. Choi, MD, PhD Massachusetts General Hospital and Harvard Medical School Project: Combination Immunotherapy with Chimeric Antigen Receptor T cells and Bispecific T-cell Engagers for Glioblastoma

2018 SITC-Bristol-Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship

David Liu, MD, MPH, MS Dana-Farber Cancer Institute Project: Dissecting Diff erential Response to Immunotherapy in Melanoma Through Clinical Computational Oncology

2018 SITC-Merck Cancer Immunotherapy Clinical Fellowship

Kelly G. Paulson, MD, PhD Fred Hutchinson Cancer Research Center Project: Turning immunotherapy responses into immunotherapy cures for the virus-associated Merkel cell carcinoma

NCI Immunotherapy Fellowship

Jason M. Redman, MD National Cancer Institute